We spoke with Professor Kev Dhaliwal, chief investigator of the SPIKE-1 trial, about how repurposing a drug in a COVID-19 trial could benefit people with cancer.
A team of Cancer Research UK-funded scientists have been investigating the role of exercise in reducing the risk of liver cancer in mice
We spoke to Dr Kate Cwynarski, who led the Stand Up To Cancer-funded MARIETTA trial, a clinical trial which details a “potentially transforming” treatment for some patients with secondary CNS lymphoma.
Here’s what we know about how the new UK-EU relationship may affect cancer services and research.
We asked two of our protein specialists, who are trying to understand how the way proteins fold affect cancer outcomes, to give their verdict on the news.
A team of our scientists at University College London have developed a potential new immunotherapy drug and caused another paradigm shift in our understanding of how cancer immunotherapy works.
We’re calling on UK governments to stand by their commitments to improving cancer survival and make sure everyone can receive the care they deserve.
As coronavirus cases continue to rise in the UK, we look at how cancer clinical trials have been affected by the pandemic.